Captor Therapeutics Spolka Akcyjna
Warsaw Stock Exchange:CTX.WA
Sector
Location
Market Cap
USD 66.35 M
Share Price
USD 12.00
Avg Daily Volume
9,068
Change (1 day)
-4.24%
Change (1 year)
-38.61%
Change (YTD)
16.79%
Captor Therapeutics Spolka Akcyjna Operating Cash Flow for the year ending December 31, 2024: USD -7.65 M
Captor Therapeutics Spolka Akcyjna Operating Cash Flow is USD -7.65 M for the year ending December 31, 2024, a -42.24% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Captor Therapeutics Spolka Akcyjna Operating Cash Flow for the year ending December 31, 2023 was USD -13.24 M, a 152.75% change year over year.
-
Captor Therapeutics Spolka Akcyjna Operating Cash Flow for the year ending December 31, 2022 was USD -5.24 M, a -25.64% change year over year.
-
Captor Therapeutics Spolka Akcyjna Operating Cash Flow for the year ending December 31, 2021 was USD -7.04 M, a 4,321.64% change year over year.
-
Captor Therapeutics Spolka Akcyjna Operating Cash Flow for the year ending December 31, 2020 was USD -159.30 K, a -113.77% change year over year.
StockViz
Competitors
Selvita S.A.
USD 9.31
SLV.WA
-0.26
-2.72%
Synektik Spólka Akcyjna
USD 57.12
SNT.WA
-0.55
-0.95%
Ryvu Therapeutics S.A.
USD 8.24
RVU.WA
-0.15
-1.84%
Celon Pharma S.A.
USD 6.28
CLN.WA
-0.13
-2.09%
Grupa Kety S.A.
USD 240.14
KTY.WA
+0.29
0.12%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|